# Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial

> **NCT07726602** · — · RECRUITING · sponsor: **OHSU Knight Cancer Institute** · enrollment: 100 (estimated)

## Conditions studied

- Muscle Invasive Bladder Urothelial Carcinoma
- Stage II Bladder Cancer AJCC v8
- Stage IIIA Bladder Cancer AJCC v8

## Interventions

- **OTHER:** Non-Interventional Study

## Key facts

- **NCT ID:** NCT07726602
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-29
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07726602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07726602, "Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07726602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*